ESR1 and breast cancer: The steroid hormone receptors ER and PR are 2 critical molecules for assessing the heterogeneity of BC and the benefit of therapy.22 However, to date, the understanding of the clinical significance of hormone receptor status, especially in single hormone receptor–positive tumors, has been poorly investigated because of limited sample sizes.